基础医学与临床 ›› 2025, Vol. 45 ›› Issue (2): 183-188.doi: 10.16352/j.issn.1001-6325.2025.02.0183

• 研究论文 • 上一篇    下一篇

4株患者原代细胞源的乳腺癌细胞系建立及初步研究

罗钰蓓1, 黄建军2, 杨文秀1, 张军红1, 李静4, 赵春华4*, 豆晓伟3*   

  1. 贵州医科大学附属医院 1.病理科;
    2.乳腺外科;
    3.临床医学研究中心,贵州 贵阳 550004;
    4.中国医学科学院基础医学研究所 北京协和医学院基础学院 组织工程研究中心,干细胞新药研发及临床转化研究北京市重点实验室(BZ0381),北京 100005
  • 收稿日期:2024-06-19 修回日期:2024-09-27 出版日期:2025-02-05 发布日期:2025-01-17
  • 通讯作者: *zhaochunhua@vip.163.com;douxw@gmc.edu.cn
  • 基金资助:
    贵州省科技计划重点项目(ZK[2023]重点033)

Establishment and preliminary study of four patient-derived primary breast cancer cell lines

LUO Yubei1, HUANG Jianjun2, YANG Wenxiu1, ZHANG Junhong1, LI Jing4, Robert Chunhua ZHAO4*, DOU Xiaowei3*   

  1. 1. Department of Pathology;
    2. Department of Breast Surgery;
    3. Clinical Research Center, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004;
    4. Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Center for Excellence in Tissue Engineering, Beijing Key Laboratory of New Drug Development and Clinical Trial of Stem Cell Therapy (BZ0381), Beijing 100005, China
  • Received:2024-06-19 Revised:2024-09-27 Online:2025-02-05 Published:2025-01-17
  • Contact: *zhaochunhua@vip.163.com;douxw@gmc.edu.cn

摘要: 目的 从患者的肿瘤组织建立可以传代的乳腺癌原代细胞系,为基础研究提供新的细胞模型。方法 经穿刺取材的患者乳腺癌组织经过Ⅱ型胶原酶消化后培养在BCMI培养基中。当细胞快速增殖时,更换为DMEM培养基。检测STR基因分型确定4种乳腺癌原代细胞的特异遗传标记。集落形成实验和球形成实验分析乳腺癌原代细胞系致瘤性。Real-time PCR 和Western blot实验分析乳腺癌原代细胞上皮间充质转换分子。转移实验和侵袭实验分析乳腺癌原代细胞的转移能力。结果 培养了4种乳腺癌原代细胞系BC25#, BC51#, BC56#和BC57#。这些乳腺癌细胞系培养基是DMEM培养基,可以传代,具有清楚的临床背景。STR基因分型确定了4种乳腺癌原代细胞系特异的遗传标记。集落形成实验和成球实验发现4种乳腺癌原代细胞系比传统的乳腺癌细胞T-47D有更强的形成肿瘤能力。Real-time PCR 和Western blot实验发现,与传统的乳腺癌细胞T-47D相比,4种乳腺癌原代细胞系E-cadherin表达降低,vimentin表达升高。迁移实验和侵袭实验发现原代细胞系BC25#比传统的乳腺癌细胞T-47D有更强的转移能力。结论 培养了4种可以传代的乳腺癌原代细胞系BC25#、BC51#、BC56#和BC57#,为乳腺癌基础研究提供了新的肿瘤细胞模型。

关键词: 乳腺癌原代细胞系, 基础研究, 新肿瘤细胞模型

Abstract: Objective To establish primary breast cancer cell lines from patient tissues and offer a new cancer cell model for basic research. Methods Breast cancer biopsy tissues were digested with type Ⅱ collagenase and cultured in BCMI medium. When the cells proliferated rapidly, the medium was switched to DMEM. STR genotyping was performed to identify specific genetic markers of the four primary breast cancer cell lines. Colony expansion assays and sphere formation assays were conducted to analyze its tumorigenicity. Real-time PCR and Western blot experiments were used to analyze the expression of the epithelial-mesenchymal transition (EMT) molecule markers. Migration and invasion assays were performed to assess the metastatic potential of the primary breast cancer cells. Results We established four primary breast cancer cell lines: BC25#, BC51#, BC56#, and BC57#. These cell lines were cultured in DMEM medium, passaged multiple times and tagged with details about their clinical past. STR genotyping identified specific genetic markers for each of the four primary breast cancer cell lines. Clonogenic and sphere formation assays revealed that the four lines have a stronger tumor-forming capability compared to the classic breast cancer cell line T-47D. Real-time PCR and Western blot experiments showed that, compared to T-47D, the four primary breast cancer cell lines have decreased E-cadherin expression and increased vimentin expression. Migration and invasion assays indicated that BC25# had a higher metastatic potential than the traditional breast cancer cell line T-47D. Conclusions Four primary breast cancer cell lines, BC25#, BC51#, BC56# and BC57# are successfully established, which may act as new cancer cell model for laboratory research of breast cancer.

Key words: primary breast cancer cell lines, basic research, new cancer cell model

中图分类号: